DHILLON AVTAR S
Insider CIK 1260933 · INO Director · STVF.OB Director, 10% owner · ONCS.OB Director, 10% owner · NMUS Director · ARTH Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ONCS ONCOSEC MEDICAL Inc | A Award | 2020-04-17 | 2020-04-21 | 12,500 | $1.55 | $19.4K | 62,052 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | A Award deriv | 2019-01-02 | 2019-01-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2018-12-06 | 2018-12-06 | 25,000 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2018-12-06 | 2018-12-06 | 25,000 | $2.00 | $50.0K | 106,002 | SEC↗ |
| NMUS Nemus Bioscience, Inc. | A Award deriv | 2018-10-10 | 2018-10-12 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| ARTH Arch Therapeutics, Inc. | A Award deriv | 2018-07-19 | 2018-07-20 | 220,000 | — | $0 | 220,000 | SEC↗ |
| ARTH Arch Therapeutics, Inc. | A Award deriv | 2018-07-19 | 2018-07-20 | 220,000 | — | $0 | 220,000 | SEC↗ |
| ARTH Arch Therapeutics, Inc. | A Award | 2018-07-19 | 2018-07-20 | 220,000 | — | $0 | 8,517,373 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | S Sale | 2018-07-05 | 2018-07-06 | 3,100 | $1.31 | $4.1K | 143,427 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | S Sale | 2018-06-29 | 2018-07-06 | 1,066 | $1.38 | $1.5K | 146,527 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | S Sale | 2018-06-28 | 2018-07-06 | 1,556 | $1.40 | $2.2K | 147,593 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | S Sale | 2018-06-27 | 2018-07-06 | 3,451 | $1.37 | $4.7K | 149,149 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | S Sale | 2018-06-26 | 2018-07-06 | 4,703 | $1.40 | $6.6K | 152,600 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | S Sale | 2018-06-25 | 2018-07-06 | 202 | $1.41 | $285 | 157,303 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | S Sale | 2018-06-22 | 2018-07-06 | 2,956 | $1.42 | $4.2K | 157,505 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | S Sale | 2018-06-21 | 2018-07-06 | 2,178 | $1.40 | $3.0K | 160,461 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | S Sale | 2018-06-20 | 2018-07-06 | 10,973 | $1.42 | $15.6K | 162,639 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | S Sale | 2018-06-19 | 2018-07-06 | 1,838 | $1.36 | $2.5K | 173,612 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | S Sale | 2018-06-18 | 2018-07-06 | 5,552 | $1.39 | $7.7K | 175,450 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | M Exercise deriv | 2018-06-15 | 2018-07-06 | 100,000 | — | $0 | 0 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | M Exercise | 2018-06-15 | 2018-07-06 | 100,000 | — | $0 | 181,002 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2018-05-12 | 2018-05-14 | 7,669 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2018-05-12 | 2018-05-14 | 7,669 | — | $0 | 81,002 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2018-05-11 | 2018-05-14 | 12,500 | — | $0 | 12,500 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2018-05-11 | 2018-05-14 | 8,170 | — | $0 | 8,170 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | A Award deriv | 2018-02-08 | 2018-02-09 | 350,000 | $1.64 | $574.0K | 647,916 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2017-05-13 | 2017-05-15 | 10,000 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2017-05-13 | 2017-05-15 | 10,000 | — | $0 | 73,333 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2017-05-12 | 2017-05-15 | 12,500 | — | $0 | 12,500 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2017-05-12 | 2017-05-15 | 7,669 | — | $0 | 7,669 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | A Award deriv | 2017-03-29 | 2017-03-31 | 20,000 | $1.34 | $26.8K | 297,916 | SEC↗ |
| ARTH Arch Therapeutics, Inc. | A Award deriv | 2017-02-03 | 2017-02-06 | 400,000 | — | $0 | 400,000 | SEC↗ |
| ARTH Arch Therapeutics, Inc. | A Award | 2017-02-03 | 2017-02-06 | 400,000 | — | $0 | 8,297,373 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | A Award deriv | 2016-12-14 | 2016-12-16 | 265,416 | — | $0 | 265,416 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | D To issuer deriv | 2016-12-14 | 2016-12-16 | 500,000 | — | $0 | 0 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | D To issuer deriv | 2016-12-14 | 2016-12-16 | 12,500 | — | $0 | 0 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | D To issuer deriv | 2016-12-14 | 2016-12-16 | 12,500 | — | $0 | 0 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | D To issuer deriv | 2016-12-14 | 2016-12-16 | 5,000 | — | $0 | 0 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | D To issuer deriv | 2016-12-14 | 2016-12-16 | 5,000 | — | $0 | 0 | SEC↗ |
| VBIO Vitality Biopharma, Inc. | A Award | 2016-07-15 | 2019-04-25 | 925,585 | — | $0 | 1,015,585 | SEC↗ |
| STVFD Vitality Biopharma, Inc. | A Award deriv | 2016-07-15 | 2016-08-17 | 925,585 | — | $0 | 1,015,585 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2016-05-13 | 2016-05-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2016-05-13 | 2016-05-16 | 10,000 | $9.33 | $93.3K | 10,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2016-05-08 | 2016-05-09 | 5,000 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2016-05-08 | 2016-05-09 | 5,000 | — | $0 | 63,333 | SEC↗ |
| ARTH Arch Therapeutics, Inc. | A Award deriv | 2016-05-03 | 2016-05-05 | 830,000 | — | $0 | 830,000 | SEC↗ |
| ARTH Arch Therapeutics, Inc. | A Award | 2016-05-03 | 2016-05-05 | 737,000 | — | $0 | 7,897,373 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | A Award deriv | 2016-03-04 | 2016-03-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | A Award deriv | 2016-03-04 | 2016-03-08 | 12,500 | $2.02 | $25.3K | 547,500 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | P Buy | 2015-10-16 | 2015-10-19 | 10,000 | $4.36 | $43.6K | 10,000 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | A Award deriv | 2015-08-20 | 2015-08-24 | 500,000 | $5.67 | $2.83M | 500,000 | SEC↗ |
| ARTH Arch Therapeutics, Inc. | A Award deriv | 2015-08-18 | 2015-08-19 | 355,000 | — | $0 | 355,000 | SEC↗ |
| STVFD Vitality Biopharma, Inc. | A Award deriv | 2015-05-21 | 2016-08-17 | 40,000 | — | $0 | 90,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2015-05-08 | 2015-05-08 | 5,000 | — | $0 | 5,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2015-05-08 | 2015-05-08 | 7,500 | $8.01 | $60.1K | 7,500 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | A Award deriv | 2015-03-03 | 2015-03-04 | 250,000 | $0.37 | $92.5K | 250,000 | SEC↗ |
| ARTH Arch Therapeutics, Inc. | A Award deriv | 2015-01-22 | 2015-01-23 | 400,000 | — | $0 | 400,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2014-05-22 | 2014-05-27 | 40,000 | $2.20 | $88.0K | 40,000 | SEC↗ |
| ARTH Arch Therapeutics, Inc. | A Award deriv | 2014-03-23 | 2014-03-25 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | A Award deriv | 2014-03-07 | 2014-03-11 | 250,000 | $0.81 | $202.5K | 250,000 | SEC↗ |
| ARTH Arch Therapeutics, Inc. | J Other | 2013-06-25 | 2013-06-26 | 160,373 | — | $0 | 7,160,373 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2013-05-17 | 2013-05-20 | 40,000 | $0.67 | $26.8K | 40,000 | SEC↗ |
| ONCS ONCOSEC MEDICAL Inc | A Award deriv | 2013-04-15 | 2013-04-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2012-08-10 | 2012-08-13 | 40,000 | $0.55 | $22.0K | 40,000 | SEC↗ |
| ONCS.OB ONCOSEC MEDICAL Inc | A Award deriv | 2012-04-25 | 2012-04-27 | 100,000 | — | $0 | 100,000 | SEC↗ |
| STVF.OB Stevia First Corp. | A Award deriv | 2012-02-24 | 2012-03-21 | 500,000 | — | $0 | 500,000 | SEC↗ |
| STVF.OB Stevia First Corp. | S Sale | 2012-02-14 | 2012-03-21 | 2,000,000 | — | $0 | 5,150,000 | SEC↗ |
| STVF.OB Stevia First Corp. | S Sale | 2012-02-14 | 2012-03-21 | 2,227,500 | — | $0 | 7,150,000 | SEC↗ |
| STVF.OB Stevia First Corp. | S Sale | 2012-02-14 | 2012-03-21 | 1,000,000 | — | $0 | 9,377,500 | SEC↗ |
| STVF.OB Stevia First Corp. | S Sale | 2012-02-14 | 2012-03-21 | 400,000 | — | $0 | 10,377,500 | SEC↗ |
| STVF.OB Stevia First Corp. | S Sale | 2012-02-14 | 2012-03-21 | 2,400,000 | — | $0 | 10,777,500 | SEC↗ |
| STVF.OB Stevia First Corp. | S Sale | 2012-02-14 | 2012-03-21 | 2,300,000 | — | $0 | 13,177,500 | SEC↗ |
| STVF.OB Stevia First Corp. | S Sale | 2012-02-14 | 2012-03-21 | 2,400,000 | — | $0 | 15,477,500 | SEC↗ |
| STVF.OB Stevia First Corp. | S Sale | 2012-02-14 | 2012-03-21 | 2,050,000 | — | $0 | 17,877,500 | SEC↗ |
| STVF.OB Stevia First Corp. | S Sale | 2012-02-14 | 2012-03-21 | 2,100,000 | — | $0 | 19,927,500 | SEC↗ |
| STVF.OB Stevia First Corp. | S Sale | 2012-02-14 | 2012-03-21 | 2,250,000 | — | $0 | 22,027,500 | SEC↗ |
| STVF.OB Stevia First Corp. | S Sale | 2012-02-14 | 2012-03-21 | 2,450,000 | — | $0 | 24,277,500 | SEC↗ |
| STVF.OB Stevia First Corp. | S Sale | 2012-02-14 | 2012-03-21 | 2,200,000 | — | $0 | 26,727,500 | SEC↗ |
| STVF.OB Stevia First Corp. | S Sale | 2012-02-03 | 2012-03-21 | 2,572,500 | — | $0 | 28,927,500 | SEC↗ |